Passing Pending Legislation Is Crucial In The Fight Against Breast Cancer

Hundreds of advocates are asking members of Congress today to pass pivotal legislation aimed at facilitating affordable access to crucial breast imaging and life-saving treatments for breast cancer. Susan G. Komen®, the world’s leading breast cancer organization, is focused on removing barriers to care during its annual Advocacy Summit.

“We have high-quality health care in the United States and the tools to detect breast cancers early but too many people cannot access or afford the services or treatment they need, impeding our ability to save all lives from breast cancer,” said Molly Guthrie, vice president of public policy and advocacy at Susan G. Komen. “Congress has introduced legislation that would resolve some access and affordability barriers, and now is the time for passage.”

Komen and its advocates are asking Congress to prioritize and move the following legislation:

H.R.3851/S.2464 – The Access to Breast Cancer Diagnosis Act eliminates patient costs for necessary diagnostic and supplemental breast imaging. Access to no-cost screening mammography is available to millions today but if the results of that screening mammogram require a follow-up diagnostic exam or an individual requires supplemental breast imaging due to being at high-risk for breast cancer, they often face hundreds to thousands of dollars in out-of-pocket costs.

H.R.3916/S.1840 – The SCREENS for Cancer Act reauthorizes the National Breast and Cervical Cancer Early Detection Program for an additional five years and modernizes the program’s ability to meet the unique needs of communities today. It allows grantees flexibility to implement innovative evidence-based interventions and aggressive outreach to under-resourced communities.

H.R.2630/S.652 – The Safe Step Act requires health plans to offer an expedient and medically reasonable exception process for step therapy protocols to help ensure patients are able to access treatments safely, efficiently and in a timely manner. Step therapy, also referred to as “fail first,” occurs when a patient is required by the patient’s insurance to try and “fail” an insurer’s preferred treatment prior to receiving coverage for the drug originally prescribed by their provider.

“These policies cannot afford to languish inaction – that is the resounding message advocates are spreading across Capitol Hill,” Guthrie added. “We appreciate the bipartisan and bicameral leadership on these bills and efforts by lawmakers to ensure everyone in this country has access to high-quality, affordable health care.”

About Susan G. Komen^®

Susan G. Komen^® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240611633515/en/